T 0222/11 (Maturation of the immune system in neonates/BAVARIAN NORDIC) of 04.03.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T022211.20160304
- Date of decision
- 4 March 2016
- Case number
- T 0222/11
- Petition for review of
- -
- Application number
- 03732280.7
- IPC class
- A61K 39/285A61K 39/245
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Modified Vaccinia Virus Ankara for the vaccination of neonates
- Applicant name
- Bavarian Nordic A/S
- Opponent name
- Emergent Product Development Germany GmbH
Sanofi Pasteur - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84European Patent Convention R 115(2)European Patent Convention R 80Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Sole request - requirements of the EPC met (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form with
- the claims of the sole request pending at the end of the oral proceedings before the board,
- a description with pages 3, 3a and 4 to 15 as filed during the oral proceedings, and
- the figures of the patent as granted.